\-\ Texto\\:\\ \ \(0\)\
\-\ labs\\ were\\ normal\\.\ \(2\)\
\-\ no\\ treatment\\ was\\ necessary\\ at\\ this\\ point\\.\\ \\ there\\ is\\ no\\ need\\ for\\ routine\\ follow\\-up\\ for\\ aml\\ \\<\\ 3cm\\,\\ unless\\ symptoms\\ arise\\.\\ \\ hemorrhage\\ is\\ the\\ most\\ common\\ complication\\ of\\ the\\ angiomyolipomas\\ \\-\\ and\\ lesions\\ larger\\ than\\ 3cm\\ may\\ be\\ resected\\ to\\ reduce\\ risk\\ of\\ hemorrhage\\.\ \(0\)\
\-\ images\\ demonstrate\\ bilateral\\ masses\\ arising\\ from\\ the\\ kidneys\\.\\ \\ the\\ masses\\ are\\ heterogeneous\\ in\\ density\\,\\ containing\\ soft\\ tissue\\ and\\ fatty\\ elements\\.\\ \\ portions\\ of\\ the\\ masses\\ enhance\\ upon\\ administration\\ of\\ iv\\ contrast\\.\\ incidentally\\,\\ the\\ mass\\ seen\\ in\\ the\\ lateral\\ right\\ kidney\\ demonstrates\\ regions\\ of\\ fat\\ attenuation\\ on\\ other\\ images\\.\\ \\ the\\ patient\\ also\\ demonstrates\\ multiple\\ calcified\\ subependymal\\ nodules\\ on\\ non\\-contrast\\ head\\ ct\\.\ \(0\)\
\-\ tuberous\\ sclerosis\\ \\(ts\\)\\,\\ renal\\ angiomyolipoma\\ \\(aml\\)\ \(0\)\
\-\ \\â\\€\\¢\\ lipoma\ \(1\)\
\-\ \\â\\€\\¢\\ angiomyolipoma\ \(2\)\
\-\ \\â\\€\\¢\\ renal\\ cell\\ carcinomas\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ metastases\ \(0\)\
\-\ 23\\ y\\.o\\.\\ man\\ with\\ a\\ known\\ disease\\ had\\ these\\ images\\ obtained\\ for\\ routine\\ follow\\-up\\.\\ \\ he\\ was\\ asymptomatic\\.\ \(0\)\
\-\ the\\ macroscopic\\ fat\\ within\\ these\\ bilateral\\ masses\\ makes\\ them\\ consistent\\ with\\ angiomyolipomas\\.\\ \\ rarely\\,\\ renal\\ cell\\ carcinomas\\ may\\ engulf\\ adjacent\\ fat\\.\\ \\ neither\\ lymphoma\\ nor\\ metastases\\ would\\ be\\ expected\\ to\\ contain\\ fat\\.\\ \\ the\\ bilateral\\ nature\\ of\\ the\\ lesions\\ is\\ consistent\\ with\\ tuberous\\ sclerosis\\.\\ \\ this\\ patient\\ also\\ displayed\\ multiple\\ calcified\\ subependymal\\ nodules\\ or\\ tubers\\ within\\ the\\ ventricular\\ system\\ of\\ the\\ brain\\,\\ an\\ additional\\ finding\\ associated\\ with\\ tuberous\\ sclerosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ tuberous\\:\\ 0\\.060574822658281374\ \(0\)\
\-\ angiomyolipomas\\:\\ 0\\.05242461993874925\ \(0\)\
\-\ aml\\:\\ 0\\.05085962803493849\ \(0\)\
\-\ masses\\:\\ 0\\.04958956906431051\ \(0\)\
\-\ 3cm\\:\\ 0\\.04770319215403447\ \(0\)\
\-\ carcinomas\\:\\ 0\\.047067072221384496\ \(0\)\
\-\ fat\\:\\ 0\\.04461652056449156\ \(0\)\
\-\ angiomyolipoma\\:\\ 0\\.04422280495997298\ \(0\)\
\-\ subependymal\\:\\ 0\\.04379353096362395\ \(0\)\
\-\ sclerosis\\:\\ 0\\.0395190802587083\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.03362691741622077\ \(0\)\
\-\ engulf\\:\\ 0\\.033119768821023125\ \(0\)\
\-\ renal\\:\\ 0\\.03305762510031849\ \(0\)\
\-\ calcified\\:\\ 0\\.031485184095734295\ \(0\)\
\-\ metastases\\:\\ 0\\.031336759227836776\ \(0\)\
\-\ nodules\\:\\ 0\\.030407887256675977\ \(0\)\
\-\ routine\\:\\ 0\\.029411559606437744\ \(0\)\
\-\ ts\\:\\ 0\\.027952503566405374\ \(0\)\
\-\ tubers\\:\\ 0\\.027543447000721578\ \(0\)\
\-\ bilateral\\:\\ 0\\.02670151582808297\ \(0\)\
\-\ displayed\\:\\ 0\\.024768223116923067\ \(0\)\
\-\ neither\\:\\ 0\\.02456856639746001\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.02441421960666125\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.02386297846731109\ \(0\)\
\-\ macroscopic\\:\\ 0\\.023851596077017236\ \(0\)\
\-\ them\\:\\ 0\\.022454933414207675\ \(0\)\
\-\ images\\:\\ 0\\.02110640204226636\ \(0\)\
\-\ lymphoma\\:\\ 0\\.020963078406776702\ \(0\)\
\-\ reduce\\:\\ 0\\.020714739817176926\ \(0\)\
\-\ makes\\:\\ 0\\.020334682317857417\ \(0\)\
\-\ contain\\:\\ 0\\.020262548762851492\ \(0\)\
\-\ elements\\:\\ 0\\.020121819909533933\ \(0\)\
\-\ unless\\:\\ 0\\.019853492197167692\ \(0\)\
\-\ cell\\:\\ 0\\.019813224992115762\ \(0\)\
\-\ lesions\\:\\ 0\\.019635712500806417\ \(0\)\
\-\ nor\\:\\ 0\\.019600957862305316\ \(0\)\
\-\ these\\:\\ 0\\.01908879563912309\ \(0\)\
\-\ portions\\:\\ 0\\.019081847946349685\ \(0\)\
\-\ fatty\\:\\ 0\\.01902786175662067\ \(0\)\
\-\ containing\\:\\ 0\\.018618805190936873\ \(0\)\
\-\ need\\:\\ 0\\.01829030700586248\ \(0\)\
\-\ arise\\:\\ 0\\.018156871009853758\ \(0\)\
\-\ resected\\:\\ 0\\.018156871009853758\ \(0\)\
\-\ consistent\\:\\ 0\\.01798539286550389\ \(0\)\
\-\ complication\\:\\ 0\\.017985174294773504\ \(0\)\
\-\ non\\-contrast\\:\\ 0\\.017901834870494102\ \(0\)\
\-\ expected\\:\\ 0\\.01786076426527457\ \(0\)\
\-\ enhance\\:\\ 0\\.017739859213915358\ \(0\)\
\-\ larger\\:\\ 0\\.01766110754581151\ \(0\)\
\-\ rarely\\:\\ 0\\.01758377490416911\ \(0\)\
\-\ 23\\:\\ 0\\.017433168381373966\ \(0\)\
\-\ nature\\:\\ 0\\.017359801714595852\ \(0\)\
\-\ lipoma\\:\\ 0\\.017146939306272365\ \(0\)\
\-\ kidneys\\:\\ 0\\.016878611593906127\ \(0\)\
\-\ regions\\:\\ 0\\.016782161568789995\ \(0\)\
\-\ incidentally\\:\\ 0\\.01662607725904375\ \(0\)\
\-\ ventricular\\:\\ 0\\.016387580043787053\ \(0\)\
\-\ necessary\\:\\ 0\\.01624498069774276\ \(0\)\
\-\ may\\:\\ 0\\.016088655527022523\ \(0\)\
\-\ point\\:\\ 0\\.01602624059648942\ \(0\)\
\-\ demonstrates\\:\\ 0\\.01602249958500589\ \(0\)\
\-\ multiple\\:\\ 0\\.015448978570637501\ \(0\)\
\-\ administration\\:\\ 0\\.015226009720614464\ \(0\)\
\-\ arising\\:\\ 0\\.015181990406592193\ \(0\)\
\-\ upon\\:\\ 0\\.014989306630163476\ \(0\)\
\-\ attenuation\\:\\ 0\\.014745154808695444\ \(0\)\
\-\ additional\\:\\ 0\\.014705779803218872\ \(0\)\
\-\ also\\:\\ 0\\.014460254022919753\ \(0\)\
\-\ system\\:\\ 0\\.014439828199145055\ \(0\)\
\-\ \\<\\:\\ 0\\.014154787671681504\ \(0\)\
\-\ within\\:\\ 0\\.013992544277992116\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.013485816123583714\ \(0\)\
\-\ iv\\:\\ 0\\.01338379801485448\ \(0\)\
\-\ risk\\:\\ 0\\.01328414870111196\ \(0\)\
\-\ would\\:\\ 0\\.013051359993227853\ \(0\)\
\-\ obtained\\:\\ 0\\.013038051934522926\ \(0\)\
\-\ kidney\\:\\ 0\\.012920100665450686\ \(0\)\
\-\ labs\\:\\ 0\\.012755253248648662\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.012397392266077627\ \(0\)\
\-\ density\\:\\ 0\\.01206708736849768\ \(0\)\
\-\ finding\\:\\ 0\\.011820006459392624\ \(0\)\
\-\ known\\:\\ 0\\.01160536946121811\ \(0\)\
\-\ adjacent\\:\\ 0\\.01159586370873076\ \(0\)\
\-\ be\\:\\ 0\\.01131121650938995\ \(0\)\
\-\ brain\\:\\ 0\\.01103584344765134\ \(0\)\
\-\ y\\.o\\:\\ 0\\.010585319453161803\ \(0\)\
\-\ head\\:\\ 0\\.010401722362978094\ \(0\)\
\-\ he\\:\\ 0\\.01023256369971253\ \(0\)\
\-\ than\\:\\ 0\\.00960965173784667\ \(0\)\
\-\ common\\:\\ 0\\.009597713356036038\ \(0\)\
\-\ for\\:\\ 0\\.009387658566215215\ \(0\)\
\-\ symptoms\\:\\ 0\\.00914016084505639\ \(0\)\
\-\ soft\\:\\ 0\\.008931016154478756\ \(0\)\
\-\ tissue\\:\\ 0\\.008692794800225724\ \(0\)\
\-\ man\\:\\ 0\\.008673527223562228\ \(0\)\
\-\ associated\\:\\ 0\\.008654345759260523\ \(0\)\
\-\ was\\:\\ 0\\.00848306886020332\ \(0\)\
\-\ most\\:\\ 0\\.00846710361256685\ \(0\)\
\-\ other\\:\\ 0\\.008453384329195058\ \(0\)\
\-\ demonstrate\\:\\ 0\\.00843970876108601\ \(0\)\
\-\ were\\:\\ 0\\.00832740917034301\ \(0\)\
\-\ this\\:\\ 0\\.008250104835314447\ \(0\)\
\-\ contrast\\:\\ 0\\.008209337711621911\ \(0\)\
\-\ lateral\\:\\ 0\\.0079256139297191\ \(0\)\
\-\ had\\:\\ 0\\.00791351853751377\ \(0\)\
\-\ \\-\\:\\ 0\\.007861495530937183\ \(0\)\
\-\ the\\:\\ 0\\.007713479404064959\ \(0\)\
\-\ treatment\\:\\ 0\\.007423248753651876\ \(0\)\
\-\ no\\:\\ 0\\.007385786701320189\ \(0\)\
\-\ patient\\:\\ 0\\.007352720437050541\ \(0\)\
\-\ seen\\:\\ 0\\.007247328820033005\ \(0\)\
\-\ is\\:\\ 0\\.007239795429846253\ \(0\)\
\-\ \\,\\:\\ 0\\.006971074648513838\ \(0\)\
\-\ on\\:\\ 0\\.006213656758501529\ \(0\)\
\-\ \\(\\:\\ 0\\.006200529839003094\ \(0\)\
\-\ \\)\\:\\ 0\\.006124787056766568\ \(0\)\
\-\ disease\\:\\ 0\\.005994581721955812\ \(0\)\
\-\ normal\\:\\ 0\\.005749409676390991\ \(0\)\
\-\ there\\:\\ 0\\.005458006680107248\ \(0\)\
\-\ from\\:\\ 0\\.005435346408387177\ \(0\)\
\-\ ct\\:\\ 0\\.0051300585982491115\ \(0\)\
\-\ mass\\:\\ 0\\.005100691016942337\ \(0\)\
\-\ an\\:\\ 0\\.005071523022681244\ \(0\)\
\-\ are\\:\\ 0\\.004999458680384557\ \(0\)\
\-\ at\\:\\ 0\\.004968940570092845\ \(0\)\
\-\ or\\:\\ 0\\.004298380896839946\ \(0\)\
\-\ right\\:\\ 0\\.003869663987598355\ \(0\)\
\-\ to\\:\\ 0\\.0036658206733303543\ \(0\)\
\-\ in\\:\\ 0\\.0036171436063541194\ \(0\)\
\-\ of\\:\\ 0\\.00350011418706403\ \(0\)\
\-\ \\.\\:\\ 0\\.0025900949083900717\ \(0\)\
\-\ with\\:\\ 0\\.0020086553835174203\ \(0\)\
\-\ a\\:\\ 0\\.001702145072182838\ \(0\)\
\-\ and\\:\\ 0\\.0015451416801048794\ \(0\)\
